Health Trials

Aortic Stenosis With Bicuspid Valve

3

Review clinical trials related to Aortic Stenosis With Bicuspid Valve. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0)

To compare down sizing strategy versus annular sizing strategy technique (control group) in Type 0 bicuspid aortic stenosis (AS) patients undergoing transcatheter aortic valve replacement (TAVR) with self-expanding valves (SEVs): a randomized superiority trial

Participants needed: 206
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Oct 3, 2025Locations: 15
Eligibility criteria

Age ≥ 65 years; [+7]

Any contra-indication for Self-expanding bioprosthetic aortic valve deployment L... [+20]

Read more
Status: Not yet recruiting

Circle Method Observational Project - Non-interventional, Retrospective, Multicenter Data Collection

The goal of this non-interventional, retrospective data analysis is to validate the circle method for patients with bicuspid aortic heart valves undergoing transcatheter aortic heart valve implantation (TAVI). The main aims are: * to assess whether patients with bicuspid aortic valves that received a TAVI suffered from fewer complications * if valve size was identical to the one determined using the circle method compared to * a case where circle method derived valve size is different from the actually implanted valve * to develop recommendations on how to size the valve using the circle method.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Institut für Pharmakologie und Präventive MedizinUpdated: Apr 22, 2025Locations: 4Duration: 12 Months
Eligibility criteria

Patients with bicuspid aortic valves who underwent aortic valve replacement with... [+1]

Read more
Status: Recruiting

HANGZHOU Solution in Bicuspid AS Undergoing TAVR

To compare supra-annular sizing and THV implantation technique (Hangzhou solution) versus annular sizing and THV implantation technique (control group) in bicuspid aortic stenosis (AS) patients undergoing transcatheter aortic valve replacement (TAVR) with self-expanding valves (SEVs): a randomized superiority trial

Participants needed: 508
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityUpdated: Jun 2, 2021Locations: 18
Eligibility criteria

Age ≥ 65 years [+9]

Any contra-indication for Self-expanding bioprosthetic aortic valve deployment [+21]

Read more